Simplify High Yield ETF CDX
Set alert
20.19 USD +0.03 +0.15%
At close · Oct 30
20.20 +0.01 +0.05%
After hours · Oct 30, 5:05 PM ET
20.05 Day range 20.28
20.16 52-week range 22.79
- YTD
- -9.34%
- 1 year
- -11.02%
- Open
- 20.28
- Prev close
- 20.16
- Mkt cap
- 383.25M
- Vol
- 101.51K
- Avg vol
- 122.05K
- EPS
- 0.799135
- P/E
- 25.26
- Div yield
- 0.00%
More statistics
- Low
- 20.05
- High
- 20.28
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 23.28
- 200-d avg
- 23.28
1D chart
Signals (11)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | 11:25 AM | 1 day ago |
| SMA: Bearish | 11:11 AM | 1 day ago |
| RSI: Oversold | 11:11 AM | 1 day ago |
| MACD: Sell Signal | 11:01 AM | 1 day ago |
| SMA: Bearish | 10:41 AM | 1 day ago |
| SMA: Bullish | 10:32 AM | 1 day ago |
| RSI: Oversold | 10:20 AM | 1 day ago |
| MACD: Buy Signal | 10:14 AM | 1 day ago |
| SMA: Bearish | 10:04 AM | 1 day ago |
| MACD: Sell Signal | 10:04 AM | 1 day ago |
| RSI: Oversold | 10:04 AM | 1 day ago |
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 26.41
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 23.28
- 200-day average
- 23.28
About Simplify High Yield ETF
The adviser seeks to achieve the fund’s investment objective by investing in high yield bonds also known as “junk bonds” primarily by purchasing exchange traded funds and applying a credit hedge derivatives strategy to the fund’s investments. Under normal circumstances, the fund will invest at least 80% of its net assets in high yield securities. The fund may invest up to 20% of its portfolio in derivatives.
News
- Fifth Third Securities Inc. Buys New Holdings in Simplify High Yield ETF $CDX
- Simplify High Yield ETF $CDX Shares Sold by NewEdge Advisors LLC
- CDX: The Active High Yield Management Working In The Opposite Direction
- Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting
- Simplify High Yield ETF (NYSEARCA:CDX) Short Interest Up 1,869.9% in March
- Simplify High Yield ETF $CDX Shares Purchased by AE Wealth Management LLC
- Simplify Provides Estimated Capital Gain Distribution Information for 2025
- Navigating Private Credit: Simplify's Christopher Getter on PCR
- CDX: A High-Yield Fund Built For The Crunch
- Not The Usual High Yield: The CDX Case
Your note
Sign in to keep a note on CDX — it syncs with the Stock Master app.